Walt H
Departement Frauenheilkunde, Universitätsspital Zürich.
Schweiz Med Wochenschr. 1998 Oct 24;128(43):1690-6.
In ancient years, knowledge about healing capacity of extracts from plants together with sunshine became evident in medicine. In our days second generation photosensitizers (they stand for plant extracts) and laser light (stands for sunshine) are ready for use in the clinic. Photomedicine recently became a selfstanding clinical area composed of photodynamic diagnosis (PDD) and photodynamic therapy (PDT) as its subdisciplines. Clinical application of photomedicine in gynaecology has been carefully prepared. By a number of experiments using in vitro and in vivo techniques a basis was developed to make possible clinical photomedical applications in gynaecology. In PDD 5-aminolevulinic acid, a stimulator for the production of cellular protoporphyrin IX, was used for the detection of tumour lesions of microscopical dimensions. Another approach in PDD called Frequency Domain Photon Migration technology makes it possible to quantify amounts of hem, water and oxygen in a given (tumour) tissue area. They are different from normal breast tissue. In PDT besides new technological components (diode lasers, light diffusers) there is specific need for new photosensitizers whose wavelength of activation is in the area of near infrared, allowing a better tissue penetration. Very recently, research results indicated that PDT does not create resistance against its own and suggest that this procedure can be used successfully even after radio- and/or chemotherapy. PDT of non-neoplastic but pathological cell proliferation such as endometriosis is very promising. One goal in gynaecology will be a reduction of the number of hysterectomies surgically performed by this minimally invasive approach.
在古代,植物提取物与阳光的治疗能力相关知识在医学中已很明显。如今,第二代光敏剂(代表植物提取物)和激光(代表阳光)已准备好在临床上使用。光医学最近成为一个独立的临床领域,由光动力诊断(PDD)和光动力疗法(PDT)作为其分支学科组成。光医学在妇科的临床应用已做好充分准备。通过一系列使用体外和体内技术的实验,为妇科临床光医学应用奠定了基础。在PDD中,5-氨基酮戊酸作为细胞原卟啉IX产生的刺激剂,用于检测微观尺寸的肿瘤病变。PDD中的另一种方法,即频域光子迁移技术,使得能够量化给定(肿瘤)组织区域中的血红蛋白、水和氧气含量。它们与正常乳腺组织不同。在PDT中,除了新的技术组件(二极管激光器、光扩散器)外,还特别需要新的光敏剂,其激活波长在近红外区域,以便更好地穿透组织。最近的研究结果表明,PDT不会产生自身抗性,并表明即使在放疗和/或化疗后,该程序也能成功使用。对非肿瘤性但病理性细胞增殖如子宫内膜异位症进行PDT非常有前景。妇科的一个目标将是通过这种微创方法减少手术切除子宫的数量。